Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Background: Neural stem cells (NSCs) have the ability to generate a variety of functional neural cell types and have a high potential for neuronal cell regeneration and recovery. Thus, they been recognized as the best source of cell therapy for neurodegenerative diseases, such as Parkinson’s disease (PD). Owing to the possibility of paracrine effect-based therapeutic mechanisms and easier clinical accessibility, extracellular vesicles (EVs), which possess very similar bio-functional components from their cellular origin, have emerged as potential alternatives in regenerative medicine. Material and methods: EVs were isolated from human fibroblast (HFF) and human NSC (F3 cells). The supernatant of the cells was concentrated by a tangential flow filtration (TFF) system. Then, the final EVs were isolated using a total EV isolation kit. Results: In this study, we demonstrate the potential protective effect of human NSC-derived EVs, showing the prevention of PD pathologies in 6-hydroxydopamine (6-OHDA)-induced in vitro and in vivo mouse models. Human NSC and F3 cell (F3)-derived EVs reduced the intracellular reactive oxygen species (ROS) and associated apoptotic pathways. In addition, F3-derived EVs induced downregulation of pro-inflammatory factors and significantly decreased 6-OHDA-induced dopaminergic neuronal loss in vivo. F3 specific microRNAs (miRNAs) such as hsa-mir-182-5p, hsa-mir-183-5p, hsa-mir-9, and hsa-let-7, which are involved in cell differentiation, neurotrophic function, and immune modulation, were found in F3-derived EVs. Conclusions: We report that human NSC-derived EVs show an effective neuroprotective property in an in vitro transwell system and in a PD model. The EVs clearly decreased ROS and pro-inflammatory cytokines. Taken together, these results indicate that NSC-derived EVs could potentially help prevent the neuropathology and progression of PD. Graphical Abstract:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NSC-EVs have been shown to inhibit neuroinflammation and ameliorate pathological events and behaviours in AD mice and PD models.444,445”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [445]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Lötvall, J., Hill, A. F., Hochberg, F., Buzás, E. I., Di Vizio, D., Gardiner, C., Gho, Y. S., Kurochkin, I. V., Mathivanan, S., Quesenberry, P., et al. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.26913 · Cited by 2,451 · cited 1×
“We identified markers in different categories of EV proteins [20].”
BackgroundRNA delivery by extracellular vesicles in mammalian cells and its applications
O’Brien, K., Breyne, K., Ughetto, S., Laurent, L. C., & Breakefield, X. O. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0251-y · Cited by 1,811 · cited 1×
“It has been reported that the RNA cargo of EVs can alter gene expression and function of recipient cells [34].”
BackgroundExtracellular Vesicles: Unique Intercellular Delivery Vehicles
Maas, S. L. N., Breakefield, X. O., & Weaver, A. M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.003 · Cited by 1,429 · cited 1×
“EVs act as individual message packets containing RNAs and proteins and migrate to proximal and distant recipient cells to alter their function and phenotype [25].”
BackgroundNeuroinflammation in Parkinson's disease and its potential as therapeutic target
Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884 · cited 2×
“These results indicate the possibility of regulating the progression of PD through the modulation of reactive glial cells and protect neurons in the PD model [11].”
BackgroundOxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778 · cited 1×
“Although the cause of dopaminergic neuronal degeneration is unknown, the involvement of mitochondrial dysfunction, neuroinflammation, protein clearance defects, and α-synuclein accumulation have been reported in postmortem examinations, brain imaging, and animal studies [2, 3].”
BackgroundCLARITY for mapping the nervous system
Chung, K., & Deisseroth, K. (2013) · Nature Methods · doi:10.1038/nmeth.2481 · Cited by 747 · cited 6×
“CLARITY technique for brain tissue clearing Mice were anesthetized with isoflurane inhalation and perfused intracardially with cold DPBS and fixed with 4% paraformaldehyde for 48 h.”
MethodInfluentialLai, C. P., Kim, E. Y., Badr, C. E., Weissleder, R., Mempel, T. R., Tannous, B. A., & Breakefield, X. O. (2015) · Nature Communications · doi:10.1038/ncomms8029 · Cited by 574 · cited 2×
“in F3‐palm‐tdTomato cells To track the behavior of EVs secreted from F3 cells, we labeled multiple EV populations with a palmitoylatedtdTomato (palm-tdTomato) lentivirus, tagged to the intracellular cell membrane area in the cytoplasm [23] (Fig.”
BackgroundMethodHypothalamic stem cells control ageing speed partly through exosomal miRNAs
Zhang, Y., Kim, M. S., Jia, B., Yan, J., Zuniga-Hertz, J. P., Han, C., & Cai, D. (2017) · Nature · doi:10.1038/nature23282 · Cited by 564 · cited 1×
“In particular, hypothalamic NSC-derived exosomes significantly slow senescence-mediated NSC loss through exosomal miRNA delivery [19].”
BackgroundParkinson disease and the immune system - Associations, mechanisms and therapeutics
Tan, E.-K., Chao, Y.-X., West, A., Chan, L.-L., Poewe, W., & Jankovic, J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0344-4 · Cited by 457 · cited 1×
“Neuroinflammation is a common feature of PD pathology [6].”
Background
Research works printed but not linked: 1
- Yuan P, Ding L, Chen H, Wang Y, Li C, Zhao S, et al. Neural stem cell-derived exosomes regulate neural stem cell differentiation through miR-9-Hes1 axis. Front Cell Dev Biol. 2021;9:601600. · DOI · Paper page
Cited by
Clinical applications of stem cell-derived exosomes
Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708
“193 In a study using NSC-derived exosomes, Lee et al. revealed that SC-exo therapy could help to prevent the neuropathology and progression of PD. 194 Working in vitro on SH-SY5Y and BV2 cells, NSC-derived exosomes could reduce the intracellular reactive oxygen species (ROS) and associated…”
BackgroundHarnessing extracellular vesicle heterogeneity for diagnostic and therapeutic applications
Carney, R. P., Mizenko, R. R., Bozkurt, B. T., Lowe, N., Henson, T., Arizzi, A., Wang, A., Tan, C., & George, S. C. (2025) · Nature Nanotechnology · doi:10.1038/s41565-024-01774-3 · Cited by 208
“Frequently, this is a top-down approach, first identifying the cells that produce EVs with a given function, and then comparing those EVs to identify similar physiochemical features 6,105 .”
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Extracellular Vesicles for Clinical Diagnostics: From Bulk Measurements to Single-Vesicle Analysis
Tran, H. L., Zheng, W., Issadore, D., Im, H., Cho, Y., Zhang, Y., Liu, D., Liu, Y., Li, B., Liu, F., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c00706 · Cited by 122
Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
Xia, X., Wang, Y., & Zheng, J. C. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00330-0 · Cited by 92
Metadata
- Authors
- Lee, E. J., Choi, Y., Lee, H. J., Hwang, D. W., & Lee, D. S.
- Affiliations
- Seoul National University (KR)
- Chungbuk National University (KR)
- Corresponding author
- Hwang, Do Won
- Lee, Dong Soo
- Venue
- Journal of Nanobiotechnology
- Published
- 2022-04-25
- Volume
- 20
- Issue
- 1
- Pages
- 198-198
- ISSN
- 1477-3155 (ISSN-L)
- PMC
- PMC9040239
- OpenAlex
- W4224322616
- Cited by
- 89
- References
- 38
- Citations by year
- 2026: 20 · 2025: 25 · 2024: 21 · 2023: 16 · 2022: 7
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Nanobiotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- National Research Foundation of Korea (NRF-2020 R1A2C2101069, 2017M3C7A1048079)
- Korea National Institute of Health (HI14C1277)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- Parkinson's disease, neural stem cells, extracellular vesicles, neuroprotection, 6-hydroxydopamine, dopaminergic neuron loss, reactive oxygen species, apoptosis, neuroinflammation, microRNA, cell therapy, paracrine signaling
- MeSH terms
- Extracellular Vesicles, Animals, Humans, Parkinson Disease, Oxidopamine, Reactive Oxygen Species, MicroRNAs, Mice, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies. https://app.cochat.ai/papers/10.1186/s12951-022-01356-2
- The paper
- Lee, E. J., Choi, Y., Lee, H. J., Hwang, D. W., & Lee, D. S. (2022). Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-022-01356-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.